Shape Memory Medical, Inc.
8
2
5
1
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 8 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 1 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (8)
AAA-SHAPE Pivotal Trial: Abdominal Aortic Aneurysm Sac Healing and Prevention of Expansion
Role: lead
False Lumen Treatment for Prevention of Aortic Growth Using Shape Memory Polymer - First-in-Human Study
Role: lead
False Lumen Treatment for Prevention of Aortic Growth Using Shape Memory Polymer - First-in-Human Study (FLAGSHIP_CHL)
Role: lead
False Lumen Treatment for Prevention of Aortic Growth Using Shape Memory Polymer - First-in-Human Study (FLAGSHIP_FRA)
Role: lead
IMPEDE and IMPEDE-FX Embolization Plug Registry
Role: lead
Abdominal Aortic Aneurysm Sac Healing and Prevention of Endoleaks
Role: lead
Aneurysm Packing With the Expandable TrelliX Coil System - A Prospective Safety Study
Role: lead
Abdominal Aortic Aneurysm Sac Healing and Prevention of Endoleaks - Netherlands
Role: lead
All 8 trials loaded